Enzo Biochem Inc. (ENZ) Hits New 1-Year High at $6.85
Enzo Biochem Inc. (NYSE:ENZ) shares hit a new 52-week high during mid-day trading on Monday . The company traded as high as $6.85 and last traded at $6.65, with a volume of 298,081 shares changing hands. The stock had previously closed at $6.50.
Separately, Zacks Investment Research raised shares of Enzo Biochem from a “sell” rating to a “hold” rating in a report on Tuesday, May 24th.
The stock’s 50-day moving average price is $6.00 and its 200 day moving average price is $5.12. The company has a market capitalization of $300.25 million and a P/E ratio of 16.99.
Enzo Biochem (NYSE:ENZ) last announced its quarterly earnings data on Wednesday, June 8th. The company reported ($0.04) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.06) by $0.02. During the same period in the prior year, the company earned ($0.07) EPS. The business had revenue of $18.16 million for the quarter, compared to the consensus estimate of $24.50 million. Equities analysts anticipate that Enzo Biochem Inc. will post ($0.23) EPS for the current year.
Enzo Biochem, Inc (Enzo) is an integrated life science and biotechnology company, which is engaged in the research, development, manufacturing and marketing of diagnostic and research products based on genetic engineering, biotechnology and molecular biology. These products are designed for the diagnosis of and/or screening for infectious diseases, cancers, genetic defects and other medically pertinent diagnostic information and are distributed in the United States and internationally.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.